Russell Investments Group Ltd. Lowers Holdings in Encompass Health Co. (NYSE:EHC)

Russell Investments Group Ltd. trimmed its holdings in Encompass Health Co. (NYSE:EHC) by 9.2% during the 4th quarter, Holdings Channel.com reports. The fund owned 207,283 shares of the company’s stock after selling 20,938 shares during the period. Russell Investments Group Ltd.’s holdings in Encompass Health were worth $13,830,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the business. Treasurer of the State of North Carolina lifted its position in shares of Encompass Health by 0.5% in the third quarter. Treasurer of the State of North Carolina now owns 48,339 shares of the company’s stock valued at $3,246,000 after acquiring an additional 231 shares in the last quarter. Linden Thomas Advisory Services LLC lifted its position in shares of Encompass Health by 1.7% in the fourth quarter. Linden Thomas Advisory Services LLC now owns 15,473 shares of the company’s stock valued at $1,032,000 after acquiring an additional 253 shares in the last quarter. Handelsbanken Fonder AB lifted its position in shares of Encompass Health by 1.9% in the fourth quarter. Handelsbanken Fonder AB now owns 15,953 shares of the company’s stock valued at $1,064,000 after acquiring an additional 300 shares in the last quarter. Personal CFO Solutions LLC lifted its position in shares of Encompass Health by 5.2% in the third quarter. Personal CFO Solutions LLC now owns 6,231 shares of the company’s stock valued at $419,000 after acquiring an additional 310 shares in the last quarter. Finally, EverSource Wealth Advisors LLC lifted its position in shares of Encompass Health by 14.7% in the third quarter. EverSource Wealth Advisors LLC now owns 2,713 shares of the company’s stock valued at $182,000 after acquiring an additional 347 shares in the last quarter. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the company. Raymond James reaffirmed a “strong-buy” rating and issued a $95.00 target price (up from $85.00) on shares of Encompass Health in a report on Friday, April 26th. Stephens reaffirmed an “overweight” rating and issued a $85.00 target price on shares of Encompass Health in a report on Tuesday, January 16th. Truist Financial lifted their target price on Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a report on Friday, February 9th. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a report on Wednesday, February 7th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $83.00 target price on shares of Encompass Health in a report on Friday, February 9th. Eight analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $90.29.

Insider Activity

In other news, CEO Mark J. Tarr sold 44,976 shares of the company’s stock in a transaction that occurred on Tuesday, April 30th. The stock was sold at an average price of $83.27, for a total transaction of $3,745,151.52. Following the transaction, the chief executive officer now owns 554,098 shares of the company’s stock, valued at $46,139,740.46. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 2.10% of the company’s stock.

Encompass Health Trading Down 0.3 %

Shares of NYSE EHC opened at $83.21 on Friday. The business’s 50 day moving average is $78.99 and its two-hundred day moving average is $71.41. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.37 and a quick ratio of 1.28. Encompass Health Co. has a 1-year low of $57.55 and a 1-year high of $85.84. The stock has a market capitalization of $8.33 billion, a P/E ratio of 22.49, a PEG ratio of 1.29 and a beta of 0.92.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Wednesday, April 24th. The company reported $1.12 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.19. Encompass Health had a return on equity of 18.01% and a net margin of 7.60%. The company had revenue of $1.32 billion for the quarter, compared to analysts’ expectations of $1.27 billion. During the same period in the previous year, the firm posted $0.88 earnings per share. The firm’s revenue for the quarter was up 13.4% on a year-over-year basis. As a group, research analysts expect that Encompass Health Co. will post 4.1 EPS for the current year.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, July 15th. Stockholders of record on Monday, July 1st will be paid a dividend of $0.15 per share. The ex-dividend date is Monday, July 1st. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.72%. Encompass Health’s dividend payout ratio is 16.22%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.